Latka logo

2021 Revenue

$251.7K

Team

3

Founded

1986

CambridgeSoft Revenue (2021)

CambridgeSoft generated $251.7K in revenue in 2021.

Supplier of desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology and chemical industries. The company provides enterprise solutions, drug discovery, and chemical research and websites, which enable customers to create, analyze, and communicate chemical, biological and scientific information.

Last updated

CambridgeSoft Revenue

In 2021, CambridgeSoft's revenue reached $251.7K.

CambridgeSoft Revenue GrowthReported revenue / ARR over time$0$60K$120K$180K$240K$300K1986198819901992199419961998200020022004200620082010201220142016201820202021$0$251.7KSource: GetLatka.com
YearMilestoneSource
2021CambridgeSoft Hit $251.7k revenue in April 2021Not recorded
1986Launched with $0 revenue

Founder / CEO

CambridgeSoft Employees & Team Size

CambridgeSoft employs approximately 3 people as of 2026.

CambridgeSoft Team GrowthReported headcount over time01223419861988199019921994199619982000200220042006200820102012201420162018202020210033Source: GetLatka.com
YearMilestoneSource
2021Reached 3 employees (April 2021)Not recorded

Frequently Asked Questions about CambridgeSoft

Who owns CambridgeSoft?

CambridgeSoft is owned by PerkinElmer, which acquired it.

What is CambridgeSoft's revenue?

As of 2021, CambridgeSoft generated $251.7K in revenue.

Who founded CambridgeSoft?

CambridgeSoft was founded by Michael Tomasic.

When was CambridgeSoft founded?

CambridgeSoft was founded in 1986.

How many employees does CambridgeSoft have?

As of 2021, CambridgeSoft had 3 employees.

Where is CambridgeSoft headquartered?

CambridgeSoft is headquartered in United States.

Compare CambridgeSoft to the industry

CambridgeSoft operates across multiple industries. Browse revenue, funding, and growth data for CambridgeSoft in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile